Hetero's Tocira gets Emergency Use Authorization from DCGI for the generic version of Tocilizumab in India.
<p>
Hyderabad-based pharma company Hetero said on Monday it has received emergency use approval from the Indian health authorities to make a generic version of Swiss giant Roche Holding AG&#39;s drug Tocilizumab used for treating COVID-19 patients.</p>
<p>
Hetero is likely to make the cheaper version of Tocilizumab available in Indian market by the end of the month under the local brand name Tocira. The drug will be produced at the company&rsquo;s plant in Hyderabad.</p>
<p>
Tocilizumab has been in high demand due to the surge in COVID-19 cases and there is a shortage of the drug worldwide.</p>
<p>
Roche&#39;s blockbuster arthritis drug, tocilizumab, cuts the risk of death among patients hospitalised with severe COVID-19. It also cuts the recovery time and reduces the need for mechanical ventilation.</p>
<p>
Hetero, also makes medicines such as remdesivir and favipiravir used for treating COVID-19 patients.</p>
Baloch Yakjehti Committee central organiser, Mahrang Baloch, called for Baloch unity in the face of…
The World Uyghur Congress welcomed the addition of 37 companies to the US Entity List…
Prime Minister Narendra Modi on Wednesday dedicated three "Made in India" frontline naval combatants INS…
Defence Minister Rajnath Singh on Wednesday highlighted the government's commitment to enhancing national security and…
Strengthening maritime cooperation between India and Mauritius, Indian Navy Ship INS Sarvekshak completed first phase…
In a historic first, the Nepali Army Band contingent participated in the Army Day Parade…